[HTML][HTML] Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Q Zhang, R Xiang, S Huo, Y Zhou, S Jiang… - Signal transduction and …, 2021 - nature.com
The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in an unprecedented setback …
syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in an unprecedented setback …
Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
CoV-AbDab: the coronavirus antibody database
MIJ Raybould, A Kovaltsuk, C Marks… - Bioinformatics, 2021 - academic.oup.com
Motivation The emergence of a novel strain of betacoronavirus, SARS-CoV-2, has led to a
pandemic that has been associated with over 700 000 deaths as of August 5, 2020 …
pandemic that has been associated with over 700 000 deaths as of August 5, 2020 …
[HTML][HTML] Real-time environmental surveillance of SARS-CoV-2 aerosols
JV Puthussery, DP Ghumra, KR McBrearty… - Nature …, 2023 - nature.com
Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded
the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling …
the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling …
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
P Pymm, A Adair, LJ Chan… - Proceedings of the …, 2021 - National Acad Sciences
Neutralizing antibodies are important for immunity against SARS-CoV-2 and as therapeutics
for the prevention and treatment of COVID-19. Here, we identified high-affinity nanobodies …
for the prevention and treatment of COVID-19. Here, we identified high-affinity nanobodies …
Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
Abstract Monoclonal anti‐SARS‐CoV‐2 immunoglobulins represent a treatment option for
COVID‐19. However, their production in mammalian cells is not scalable to meet the global …
COVID‐19. However, their production in mammalian cells is not scalable to meet the global …
An update of anti-viral treatment of COVID-19.
S ŞİMŞEK YAVUZ… - Turkish journal of …, 2021 - search.ebscohost.com
Background/aim: Currently there is not an effective antiviral treatment for COVID-19, but a
large number of drugs have been evaluated since the beginning of the pandemic, and many …
large number of drugs have been evaluated since the beginning of the pandemic, and many …
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
The emergence of SARS-CoV-2 variants threatens current vaccines and therapeutic
antibodies and urgently demands powerful new therapeutics that can resist viral escape. We …
antibodies and urgently demands powerful new therapeutics that can resist viral escape. We …
[HTML][HTML] Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
NA Valdez-Cruz, E García-Hernández, C Espitia… - Microbial cell …, 2021 - Springer
SARS-CoV-2 is a novel β-coronavirus that caused the COVID-19 pandemic disease, which
spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far …
spread rapidly, infecting more than 134 million people, and killing almost 2.9 million thus far …
[HTML][HTML] Research progress and applications of nanobody in human infectious diseases
Infectious diseases, caused by pathogenic microorganisms, are capable of affecting crises.
In addition to persistent infectious diseases such as malaria and dengue fever, the vicious …
In addition to persistent infectious diseases such as malaria and dengue fever, the vicious …